ERBB2 and breast carcinoma: In contrast to the previous study, we could not verify the correlation between SOX2 expression status and breast cancer with basal-like features that is triple negativity for hormone receptors and HER2 [16], although associations with other parameters reflecting tumor aggressiveness such as tumor size and positive lymphonodal status were observed.